2021 Partners
Ulysses Neuroscience
Innovation Partner
Ulysses Neuroscience Ltd. is a Private R&D Organization having a more collaborative way of working with pharmaceutical companies. Our translational research investigates the molecular mechanisms leading to the synaptic pathology and neuroinflammatory events which may anticipate development of psychiatric and neurodegenerative disorders.
Genomenon
Innovation Partner
Genomenon is a genomic health IT company that keeps pace with the constant advancements made in genomics and connects that research to patient DNA to help diagnose and treat patients with rare genetic diseases and cancer. Mastermind Genomic Landscapes inform pharmaceutical companies on precision medicine development, deliver genomic biomarkers for clinical trial target selection, and support CDx regulatory submissions with empirical evidence. Genomenon was named Company of the Year in Clinical Genomics Interpretation by Frost & Sullivan